Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Advances in therapy
View this publicationAdvances in therapy
View this publicationJournal of travel medicine
View this publicationJournal of neurochemistry
View this publicationBiomedicines
View this publicationJournal of clinical medicine
View this publicationNature reviews bioengineering
View this publicationCardiovascular research
View this publicationFrontiers in immunology
View this publicationBiomedicines
View this publicationFrontiers in immunology
View this publication